Conditional inactivation of Smarcb1 in mice (Smarcb1Flox/Flox, Mx-Cre plus polyI/polyC treatment) results in rapid cancer susceptibility, with all animals developing tumors at a median age of 11 weeks [131]. The gene discussed is SMARCB1; the disease is cancer.